Cleared Traditional

K830912 - TDX T-UPTAKE

K830912 is an FDA 510(k) clearance for TDX T-UPTAKE, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code KHQ cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K830912 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1983
Decision
22d
Days
Class 2
Risk

K830912 is an FDA 510(k) clearance for the TDX T-UPTAKE. Classified as Radioassay, Triiodothyronine Uptake (product code KHQ), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on April 12, 1983 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1715 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K830912

510(k) Number K830912 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 1983
Decision Date April 12, 1983
Days to Decision 22 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 88d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KHQ Device Classification - Class 2, Special Controls

Product Code KHQ Radioassay, Triiodothyronine Uptake
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - KHQ Radioassay, Triiodothyronine Uptake

All 64
Devices cleared under the same product code (KHQ) and FDA review panel - the closest regulatory comparables to K830912.
TRI-TUBE RIA
K840589 · Nuclear Medical Laboratories, Inc. · Mar 1984
ACA THYROXINE UPTAKE ANALYTICAL TEST
K833703 · E.I. Dupont DE Nemours & Co., Inc. · Jan 1984
MAGIC TM 125I T3 UPTAKE RADIOASSAY
K831613 · Corning Medical & Scientific · Aug 1983
ADVANCE TM T-3 UPTAKE ASSAY
K822592 · Syva Co. · Oct 1982
LEECO T3% DIAGNOSTIC KIT
K822575 · Leeco Diagnostics, Inc. · Sep 1982
T3 UPTAKE KITS
K822612 · Pcl-Ria, Inc. · Sep 1982